A solid earnings report lifted the health tech stock. Shares of Doximity (DOCS 35.19%), the social network for doctors, were jumping today after the company easily beat estimates in its fiscal first-quarter earnings report. The stock was up 33.1% as of 1:04 p.m. ET on the news. Doximity delights The social media company reported revenue growth of 17% to $126.7 million in the period ended June 30, which easily beat the consensus estimate of $119.9 million. Profit growth soared as well with adjusted earnings ...

Doximity (NYSE:DOCS) stock is rising higher on Friday following the release of the medical cloud-based digital platform company's earnings report for its fiscal first quarter of 2025. That earnings report starts off strong with adjusted EPS of 28 cents per share. This is better than the 23 cents per share Wall Street was expecting. It's also an improvement over the 19 cents per share reported in the same period of the year prior. Adding to this is revenue of $126.7 million in fiscal Q1. That's another beat ...

Financial Data and Key Metrics Changes - Doximity reported Q1 2025 revenue of $127 million, reflecting a 17% year-on-year growth and exceeding the high end of guidance by 5% [4][5] - Adjusted EBITDA margin was 52%, amounting to $66 million, which is 18% above the high end of guidance, with adjusted EBITDA growing 42% year-on-year [5][11] - Non-GAAP gross margin increased to 92% from 90% in the prior year [11] Business Line Data and Key Metrics Changes - The top 20 clients grew revenue by 21% on a trailing 12-month basis, indicating strong demand from major pharmaceutical manufacturers [5][11] - Doximity ended the quarter with 102 customers contributing at least $500,000 each in subscription-based revenue, a 16% increase from the previous year [11] Market Data and Key Metrics Changes - Unique active prescribers using Doximity's tools reached a record 590,000, with significant growth in daily active users [6][7] - The company reported that its new products, particularly in point of care and formulary, saw sales increase by over 70% year-on-year [14] Company Strategy and Development Direction - Doximity is focused on leveraging AI to enhance its offerings, including the launch of Doximity GPT, which has seen over 1.5 million prompts completed [7][8] - The new client portal is designed to provide real-time insights and actionable recommendations, enhancing client engagement and driving upsell opportunities [9][10] Management's Comments on Operating Environment and Future Outlook - Management expressed confidence in the company's competitive position and ability to gain market share, despite acknowledging ongoing macroeconomic uncertainties [15] - For Q2 2025, Doximity expects revenue in the range of $126.5 million to $127.5 million, representing a 12% growth at the midpoint [13] Other Important Information - Free cash flow for Q1 was $39.5 million, a decrease of 29% year-on-year, primarily due to the timing of tax payments [12] - The company repurchased $48.2 million worth of shares, reducing fully diluted shares outstanding by 6% since Q1 of last year [12] Q&A Session Summary Question: Updated stance on pharma budget growth for the full year - Management believes overall budget growth for pharma customers remains at roughly 5% to 7%, but clients are more comfortable deploying dollars earlier in the upsell cycle due to the strong product portfolio [16] Question: Driving factors behind record engagement on the platform - Daily active users grew significantly as Doximity becomes a key tool for doctors' mobile medical workflows, with more physicians working remotely [18] Question: Trends in client portal usage - Clients are using the portal for real-time insights, which has led to faster growth among brands with access compared to the overall pharma business [21] Question: Variability in company growth rates - Management noted that quarterly variations in revenue are expected due to the timing of upsells and product launches, emphasizing the importance of annual performance [22] Question: Performance of the curative business segment - The curative business saw strong quarter-over-quarter growth, with a focus on leveraging AI for recruiting [55]

Doximity (DOCS) came out with quarterly earnings of $0.28 per share, beating the Zacks Consensus Estimate of $0.22 per share. This compares to earnings of $0.19 per share a year ago. These figures are adjusted for nonrecurring items. This quarterly report represents an earnings surprise of 27.27%. A quarter ago, it was expected that this medical social networking site would post earnings of $0.20 per share when it actually produced earnings of $0.25, delivering a surprise of 25%. Over the last four quarters ...

Table of Contents Title of each class Trading Symbol(s) Name of exchange on which registered DOCS The New York Stock Exchange Class A common stock, $0.001 par value per share UNITED STATES SECURITIES AND EXCHANGE COMMISSION WASHINGTON, D.C. 20549 _________________________________________________________________________________________________________________ FORM 10-Q _________________________________________________________________________________________________________________ (Mark One) ☒ QUARTERLY REPO ...

Exhibit 99.1 Doximity Announces Fiscal 2025 First Quarter Financial Results Total revenues of $126.7 million, up 17% year-over-year Net income growth of 46% and adjusted EBITDA growth of 42% year-over-year SAN FRANCISCO, Calif., August 8, 2024 -- Doximity, Inc. (NYSE: DOCS), the leading digital platform for U.S. medical professionals, today announced results of its fiscal 2025 first quarter ended June 30, 2024. "We were pleased to deliver strong profits and record engagement last quarter, as we beat on both ...

The upcoming earnings release of Doximity will be of great interest to investors. The company's earnings report is expected on August 8, 2024. The company is forecasted to report an EPS of $0.22, showcasing a 15.79% upward movement from the corresponding quarter of the prior year. Alongside, our most recent consensus estimate is anticipating revenue of $119.88 million, indicating a 10.52% upward movement from the same quarter last year. Doximity (DOCS) closed the most recent trading day at $28.66, moving +1 ...

However, in the post-pandemic era, manual workforce shortage within healthcare has become a worldwide problem, weighing heavily on healthcare infrastructure. In April 2023, the National Council of State Boards of Nursing revealed that within United States, 100,000 nurses left the workforce during the pandemic, and by 2027, almost 900,000, or almost one-fifth of 4.5 million total registered nurses, intend to leave the workforce, threatening the national health care system at large if solutions are not enacte ...

Market participants will be closely following the financial results of Doximity in its upcoming release. It is anticipated that the company will report an EPS of $0.22, marking a 15.79% rise compared to the same quarter of the previous year. At the same time, our most recent consensus estimate is projecting a revenue of $119.88 million, reflecting a 10.52% rise from the equivalent quarter last year. The most recent trading session ended with Doximity (DOCS) standing at $27.97, reflecting a +0.5% shift from ...

Doximity operates a digital platform that provides connections between, medical information to, and patient scheduling tools for medical professionals. The Class Period begins on February 9, 2022, when Doximity released its quarterly financial results for the third quarter of fiscal year 2022, after the market closed the night prior. During the accompanying quarterly investor earnings call afterhours on February 8, 2022, Defendant Anna Bryson, the Company's Chief Financial Officer, emphasized that "marketer ...